Peanut Allergy Epidemiology Forecast

DelveInsight's 'Peanut Allergy - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Peanut Allergy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


Study Period: 2017-2030


Peanut Allergy Understanding

The DelveInsight Peanut Allergy epidemiology report gives a thorough understanding of the Peanut Allergy by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Peanut Allergy in the US, Europe, and Japan. The report covers the detailed information of the Peanut Allergy epidemiology scenario in seven major countries (US, EU5, and Japan).


Peanut Allergy Epidemiology Perspective by DelveInsight

The Peanut Allergy epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Peanut Allergy epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Peanut Allergy epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Peanut Allergy Detailed Epidemiology Segmentation

The Peanut Allergy epidemiology covered in the report provides historical as well as forecasted Peanut Allergy epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Peanut Allergy report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.


Scope of the Report

  • The Peanut Allergy report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Peanut Allergy Epidemiology Report and Model provide an overview of the risk factors and global trends of Peanut Allergy in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Peanut Allergy in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Peanut Allergy
  • The report provides the segmentation of the Peanut Allergy epidemiology


Report Highlights

  • 11-Year Forecast of Peanut Allergy epidemiology
  • 7MM Coverage
  • Total Cases of Peanut Allergy
  • Total Cases of Peanut Allergy according to segmentation
  • Diagnosed cases of Peanut Allergy


KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.


Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Peanut Allergy?
  • What are the key findings pertaining to the Peanut Allergy epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Peanut Allergy across the 7MM during the forecast period (2017-2030)?
  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Peanut Allergy?
  • What are the currently available treatments of Peanut Allergy?


Reasons to buy

  • The Peanut Allergy Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Peanut Allergy market
  • Quantify patient populations in the global Peanut Allergy market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Peanut Allergy therapeutics in each of the markets covered
  • Understand the magnitude of Peanut Allergy population by its epidemiology
  • The Peanut Allergy Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights 

2. Executive Summary of Peanut Allergy

3. Peanut Allergy: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Peanut Allergy Epidemiology Scenario in the 7MM (2017- 2030)

5.4. United States Epidemiology

5.4.1. Peanut Allergy Epidemiology Scenario in the United States (2017- 2030)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. Peanut Allergy Epidemiology Scenario in Germany (2017- 2030)

5.5.2. France Epidemiology

5.5.2.1. Peanut Allergy Epidemiology Scenario in France (2017- 2030)

5.5.3. Italy Epidemiology

5.5.3.1. Peanut Allergy Epidemiology Scenario in Italy (2017- 2030)

5.5.4. Spain Epidemiology

5.5.4.1. Peanut Allergy Epidemiology Scenario in Spain (2017- 2030)

5.5.5. United Kingdom Epidemiology

5.5.5.1. Peanut Allergy Epidemiology Scenario in the United Kingdom (2017-2030)

5.6. Japan Epidemiology

5.6.1. Peanut Allergy Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Peanut Allergy Treatment and Management

6.2. Peanut Allergy Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

Table 1  Peanut Allergy Epidemiology in 7MM (2017-2030)

Table 2 Peanut Allergy Diagnosed and Treatable Cases in 7MM (2017-2030)

Table 3 Peanut Allergy Epidemiology in the United States (2017-2030)

Table 4 Peanut Allergy Diagnosed and Treatable Cases in the United States (2017-2030)

Table 5 Peanut Allergy Epidemiology in Germany (2017-2030)

Table 6 Peanut Allergy Diagnosed and Treatable Cases in Germany (2017-2030)

Table 7 Peanut Allergy Epidemiology in France (2017-2030)

Table 8 Peanut Allergy Diagnosed and Treatable Cases in France (2017-2030)

Table 9 Peanut Allergy Epidemiology in Italy (2017-2030)

Table 10 Peanut Allergy Diagnosed and Treatable Cases in Italy (2017-2030)

Table 11 Peanut Allergy Epidemiology in Spain (2017-2030)

Table 12 Peanut Allergy Diagnosed and Treatable Cases in Spain (2017-2030)

Table 13 Peanut Allergy Epidemiology in the United Kingdom (2017-2030)

Table 14 Peanut Allergy Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Table 15 Peanut Allergy Epidemiology in Japan (2017-2030)

Table 16 Peanut Allergy Diagnosed and Treatable Cases in Japan (2017-2030)

Figure 1 Peanut Allergy Epidemiology in 7MM (2017-2030)

Figure 2 Peanut Allergy Diagnosed and Treatable Cases in 7MM (2017-2030)

Figure 3 Peanut Allergy Epidemiology in the United States (2017-2030)

Figure 4 Peanut Allergy Diagnosed and Treatable Cases in the United States (2017-2030)

Figure 5 Peanut Allergy Epidemiology in Germany (2017-2030)

Figure 6 Peanut Allergy Diagnosed and Treatable Cases in Germany (2017-2030)

Figure 7 Peanut Allergy Epidemiology in France (2017-2030)

Figure 8 Peanut Allergy Diagnosed and Treatable Cases in France (2017-2030)

Figure 9 Peanut Allergy Epidemiology in Italy (2017-2030)

Figure 10 Peanut Allergy Diagnosed and Treatable Cases in Italy (2017-2030)

Figure 11 Peanut Allergy Epidemiology in Spain (2017-2030)

Figure 12 Peanut Allergy Diagnosed and Treatable Cases in Spain (2017-2030)

Figure 13 Peanut Allergy Epidemiology in the United Kingdom (2017-2030)

Figure 14 Peanut Allergy Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Figure 15 Peanut Allergy Epidemiology in Japan (2017-2030)

Figure 16 Peanut Allergy Diagnosed and Treatable Cases in Japan (2017-2030)

*The table of contents is not exhaustive; will be provided in the final report



  • Tags:
  • Peanut Allergy Epidemiology
  • Peanut Allergy
  • Peanut Allergy Pipeline
  • Peanut Allergy Companies
  • Peanut Allergy prevalent populatio...
  • Peanut Allergy incident population
  • Peanut Allergy patients diagnosed
  • Peanut Allergy treatment algorithm...

Forward to Friend

Need A Quote